Four of five patients participating in a trial of an experimental protocol designed to induce immune tolerance to HLA-mismatched kidney transplants have been able to discontinue immunosuppressive drugs. The report describes the first successful, intentional induction of tolerance across the HLA barrier in a group of transplant recipients. Combined organ and bone marrow transplant allows patients to halt immunosuppression.